首页 > 最新文献

Iranian Journal of Radiation Research最新文献

英文 中文
Assessment of patient dose in routine digital radiography in Iran 伊朗常规数字x线摄影患者剂量评估
Q4 Health Professions Pub Date : 2020-07-10 DOI: 10.18869/ACADPUB.IJRR.18.3.449
B. Mohsenzadeh, M. Deevband, R. Paydar, M. Ghorbani
Background: The present study aimed to investigate patient dose in common X-ray examinations to estimate effective dose in the digital radiography in Iran. Materials and Methods: Entrance surface dose (ESD) was measured based on applied exposure parameters for the common actual examination; and then effective dose (ED) was calculated by use of PCXMC software. The study was conducted on 15358 patients in 85 X-ray rooms; and the necessary data was collected for five age groups, 0-1 year, 1-5 years, 5-10 years, 10-15 years old and adults in each projection. Results: The ranges of ESD and ED in different examinations for all the age groups are 0.02-10.20 mGy and 2.42378.96 μSv respectively. Conclusion: The effective dose as criteria can be used to reduce patients' doses. The special considerations such as: adequate training of imaging staff; updating clinical audits; patient dose considerations; implementation of systematic and regular quality assurance and quality control programs in medical imaging departments should be taken into account to optimize radiological practices.
背景:本研究旨在调查伊朗普通X射线检查中的患者剂量,以估计数字射线照相的有效剂量。材料和方法:根据常用实际检查的暴露参数测量入射表面剂量(ESD);然后使用PCXMC软件计算有效剂量(ED)。这项研究是在85个X光室对15358名患者进行的;并收集了五个年龄组的必要数据,即0-1岁、1-5岁、5-10岁、10-15岁和每个投影中的成年人。结果:各年龄组不同检查的ESD和ED范围分别为0.02~10.20mGy和2.42378.96μSv。结论:以有效剂量为标准可以减少患者的用药剂量。特殊考虑因素如:对成像工作人员进行充分培训;更新临床审计;患者剂量考虑;应考虑在医学影像部门实施系统和定期的质量保证和质量控制计划,以优化放射实践。
{"title":"Assessment of patient dose in routine digital radiography in Iran","authors":"B. Mohsenzadeh, M. Deevband, R. Paydar, M. Ghorbani","doi":"10.18869/ACADPUB.IJRR.18.3.449","DOIUrl":"https://doi.org/10.18869/ACADPUB.IJRR.18.3.449","url":null,"abstract":"Background: The present study aimed to investigate patient dose in common X-ray examinations to estimate effective dose in the digital radiography in Iran. Materials and Methods: Entrance surface dose (ESD) was measured based on applied exposure parameters for the common actual examination; and then effective dose (ED) was calculated by use of PCXMC software. The study was conducted on 15358 patients in 85 X-ray rooms; and the necessary data was collected for five age groups, 0-1 year, 1-5 years, 5-10 years, 10-15 years old and adults in each projection. Results: The ranges of ESD and ED in different examinations for all the age groups are 0.02-10.20 mGy and 2.42378.96 μSv respectively. Conclusion: The effective dose as criteria can be used to reduce patients' doses. The special considerations such as: adequate training of imaging staff; updating clinical audits; patient dose considerations; implementation of systematic and regular quality assurance and quality control programs in medical imaging departments should be taken into account to optimize radiological practices.","PeriodicalId":14498,"journal":{"name":"Iranian Journal of Radiation Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42372760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Comparison of different calculation indexes with dose volume histogram parameters for evaluation of radiation treatment plans in gynecologic malignancies 不同计算指标与剂量-体积直方图参数在妇科恶性肿瘤放射治疗方案评价中的比较
Q4 Health Professions Pub Date : 2020-07-10 DOI: 10.18869/ACADPUB.IJRR.18.3.477
Aysun Inal, E. Duman, E. Ozkan
Background: We aimed to investigate the accordance of Critical Organ Scoring Index (COSI), Conformity Index (CI) and Normal Tissue Complication Probability (NTCP) parameters with Dose Volume Histograms (DVH) used for evaluation of 3 different pelvic radiotherapy plans. Materials and Methods: Ten gynecologic carcinoma patients who underwent adjuvant radiotherapy were enrolled in this study. Treatment plans were created with conformal treatment planning (3DCRT) and intensity modulated radiation therapy (IMRT) to a total dose of 50.4 Gy in 28 fractions. Initially, volume related dose evaluation was done via DVH. Subsequently, HI, CI, COSI and NTCP for selected normal tissues were calculated for each plan and compared with DVH parameters. Finally, a graphical demonstration was evaluated to see if the results were in accordance with DVH. Results: CI results were statistically significant in favor of IMRT (p<0.001). Rectum V40Gy decreased with 9IMRT compared to 3DCRT and 7IMRT (p=0.013 and p=0.013). V40Gy for bladder was also lower with 9IMRT compared with 3DCRT and 7IMRT (p=0.005 and p=0.012). COSI calculations revealed better small intestine protection in IMRT plans similar with DVH (p=0.005 and p=0.022). Femoral heads were better protected with IMRT plans were better compared to 3DCRT in NTCP calculations (p=0.002). Normal tissue protection was worst with 3DCRT via both DVH and COSI evaluations (p=0.001 and p<0.001 respectively). Conclusion: Using the indexes in this study to decide the most appropriate plan among multiple treatment plans in gynecologic cancer patients will be timesaving and easier in comparison with evaluating the DVH of every alternative plan.
背景:探讨3种不同盆腔放疗方案中,关键器官评分指数(COSI)、符合性指数(CI)和正常组织并发症概率(NTCP)参数与剂量-体积直方图(DVH)的一致性。材料与方法:选取10例接受辅助放疗的妇科癌患者作为研究对象。治疗方案采用适形治疗计划(3DCRT)和调强放疗(IMRT),总剂量为50.4 Gy,分28个分量。最初,通过DVH进行体积相关剂量评估。随后计算各方案选取正常组织的HI、CI、COSI和NTCP,并与DVH参数进行比较。最后,通过图形演示来评估结果是否符合DVH。结果:CI结果支持IMRT有统计学意义(p<0.001)。与3DCRT和7IMRT相比,9IMRT组直肠V40Gy降低(p=0.013和p=0.013)。9IMRT组膀胱V40Gy也低于3DCRT和7IMRT组(p=0.005和p=0.012)。COSI计算显示,与DVH相似的IMRT计划中小肠保护效果更好(p=0.005和p=0.022)。在NTCP计算中,IMRT方案对股骨头的保护优于3DCRT方案(p=0.002)。通过DVH和COSI评估,3DCRT对正常组织的保护最差(p=0.001和p<0.001)。结论:利用本研究指标在妇科肿瘤患者的多种治疗方案中确定最合适的方案,与评估每种备选方案的DVH相比,节省时间,更容易。
{"title":"Comparison of different calculation indexes with dose volume histogram parameters for evaluation of radiation treatment plans in gynecologic malignancies","authors":"Aysun Inal, E. Duman, E. Ozkan","doi":"10.18869/ACADPUB.IJRR.18.3.477","DOIUrl":"https://doi.org/10.18869/ACADPUB.IJRR.18.3.477","url":null,"abstract":"Background: We aimed to investigate the accordance of Critical Organ Scoring Index (COSI), Conformity Index (CI) and Normal Tissue Complication Probability (NTCP) parameters with Dose Volume Histograms (DVH) used for evaluation of 3 different pelvic radiotherapy plans. Materials and Methods: Ten gynecologic carcinoma patients who underwent adjuvant radiotherapy were enrolled in this study. Treatment plans were created with conformal treatment planning (3DCRT) and intensity modulated radiation therapy (IMRT) to a total dose of 50.4 Gy in 28 fractions. Initially, volume related dose evaluation was done via DVH. Subsequently, HI, CI, COSI and NTCP for selected normal tissues were calculated for each plan and compared with DVH parameters. Finally, a graphical demonstration was evaluated to see if the results were in accordance with DVH. Results: CI results were statistically significant in favor of IMRT (p<0.001). Rectum V40Gy decreased with 9IMRT compared to 3DCRT and 7IMRT (p=0.013 and p=0.013). V40Gy for bladder was also lower with 9IMRT compared with 3DCRT and 7IMRT (p=0.005 and p=0.012). COSI calculations revealed better small intestine protection in IMRT plans similar with DVH (p=0.005 and p=0.022). Femoral heads were better protected with IMRT plans were better compared to 3DCRT in NTCP calculations (p=0.002). Normal tissue protection was worst with 3DCRT via both DVH and COSI evaluations (p=0.001 and p<0.001 respectively). Conclusion: Using the indexes in this study to decide the most appropriate plan among multiple treatment plans in gynecologic cancer patients will be timesaving and easier in comparison with evaluating the DVH of every alternative plan.","PeriodicalId":14498,"journal":{"name":"Iranian Journal of Radiation Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48682873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complication analysis of breast cancer patients after mastectomy with immediate autologous breast reconstruction and adjuvant radiotherapy 乳腺癌癌症患者乳房切除术后即刻自体乳房重建及辅助放疗并发症分析
Q4 Health Professions Pub Date : 2020-07-10 DOI: 10.18869/ACADPUB.IJRR.18.3.389
Soo Jung Lee, Y. Kwak, E. Park, S. Lee, S. Sung, B. Choi
{"title":"Complication analysis of breast cancer patients after mastectomy with immediate autologous breast reconstruction and adjuvant radiotherapy","authors":"Soo Jung Lee, Y. Kwak, E. Park, S. Lee, S. Sung, B. Choi","doi":"10.18869/ACADPUB.IJRR.18.3.389","DOIUrl":"https://doi.org/10.18869/ACADPUB.IJRR.18.3.389","url":null,"abstract":"","PeriodicalId":14498,"journal":{"name":"Iranian Journal of Radiation Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41741831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brainstem schwannoma: A case report and review of clinical and imaging features 脑干神经鞘瘤1例报告及临床和影像学特征回顾
Q4 Health Professions Pub Date : 2020-07-10 DOI: 10.18869/ACADPUB.IJRR.18.3.605
Xiao Liang, W. Shi, Xin Wang, Jiang-bo Qin, Le Wang, Xiao-feng Wu, Hui Zhang, Yan Tan
Background: Intracerebral schwannoma is an extremely rare disease, accounting for fewer than 1% of intracranial schwannomas. The most common site for this type of schwannoma is the cerebral hemisphere, especially the frontal and temporal lobes; brainstem schwannoma is infrequent. Case Description: Here, we report a 51-year-old man with a monthlong history of blurred vision and weakness in his left lower limb. Magnetic resonance imaging showed a heterogeneous cystic tumor with a solid nodule arising from the brainstem. The patient underwent a craniotomy with complete resection of the tumor, which was confirmed to be a brainstem schwannoma by histopathological examination. We also performed a literature review of the 19 reported cases of brainstem schwannoma. Conclusions: Brainstem schwannomas predominated in children and young adults (60% of cases occurred in patients ≤ 30 years of age), and were more common in females (65%). Most of these schwannomas exhibited heterogeneous intensity, containing cystic (78%) and solid-enhanced components. The vast majority of reported cases (94.9%) followed a benign course, with an improved prognosis following tumor resection.
背景:脑内神经鞘瘤是一种极为罕见的疾病,占颅内神经鞘瘤的不到1%。这种类型的神经鞘瘤最常见的部位是大脑半球,尤其是额叶和颞叶;脑干神经鞘瘤并不常见。病例描述:在此,我们报告一位51岁的男性,他有一个月的视力模糊和左下肢无力的病史。磁共振成像显示脑干的非均匀囊性肿瘤伴实性结节。患者行开颅手术并完全切除肿瘤,经组织病理学检查证实为脑干神经鞘瘤。我们也对19例脑干神经鞘瘤的报道进行了文献回顾。结论:脑干神经鞘瘤以儿童和青壮年为主(60%的病例发生在≤30岁的患者中),在女性中更为常见(65%)。大多数神经鞘瘤表现出不均匀的强度,包含囊性(78%)和固体增强成分。绝大多数报告病例(94.9%)为良性病程,肿瘤切除后预后改善。
{"title":"Brainstem schwannoma: A case report and review of clinical and imaging features","authors":"Xiao Liang, W. Shi, Xin Wang, Jiang-bo Qin, Le Wang, Xiao-feng Wu, Hui Zhang, Yan Tan","doi":"10.18869/ACADPUB.IJRR.18.3.605","DOIUrl":"https://doi.org/10.18869/ACADPUB.IJRR.18.3.605","url":null,"abstract":"Background: Intracerebral schwannoma is an extremely rare disease, accounting for fewer than 1% of intracranial schwannomas. The most common site for this type of schwannoma is the cerebral hemisphere, especially the frontal and temporal lobes; brainstem schwannoma is infrequent. Case Description: Here, we report a 51-year-old man with a monthlong history of blurred vision and weakness in his left lower limb. Magnetic resonance imaging showed a heterogeneous cystic tumor with a solid nodule arising from the brainstem. The patient underwent a craniotomy with complete resection of the tumor, which was confirmed to be a brainstem schwannoma by histopathological examination. We also performed a literature review of the 19 reported cases of brainstem schwannoma. Conclusions: Brainstem schwannomas predominated in children and young adults (60% of cases occurred in patients ≤ 30 years of age), and were more common in females (65%). Most of these schwannomas exhibited heterogeneous intensity, containing cystic (78%) and solid-enhanced components. The vast majority of reported cases (94.9%) followed a benign course, with an improved prognosis following tumor resection.","PeriodicalId":14498,"journal":{"name":"Iranian Journal of Radiation Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46353301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Patient radiation dosimetry during interventional cardiac procedures 心脏介入手术中的患者辐射剂量测定
Q4 Health Professions Pub Date : 2020-07-10 DOI: 10.18869/ACADPUB.IJRR.18.3.511
F. Omidvar, F. Bouzarjomehri, F. Falahati, M. Zare
Background: Cardiac catheterization plays an essential role in the evaluation of suspected heart failure patients. This work aimed to determine the mean effective dose of patients undergoing catheterization tests and to estimate the associated radiation risk of malignancy. Material and Methods: Measurements were performed during 65 coronary angiographies (CA), 70 coronary angioplasties (PTCA) 27, radio fluoroscopy (RF) ablations and 25 electro physiologies procedures in a dedicated laboratory. The procedures were undertaken with the Siemens and General Electric X-ray equipment. A dose area product (DAP) meter was also used. The DAP values and fluoroscopy times were recorded for each patient. Results: The mean DAP values and patient effective doses were 19.53 Gy.cm and 1.71 mSv for CA, 49.74 Gy.cm2 and 4.57 mSv for PTCA, 153.34 Gy.cm and 16.38 mSv for ablations and 14.88 Gy.cm and 1.65 mSv for electrophysiology, respectively. The patient radiation risk was estimated at 13, 1.3, 1.3, 3.6 fatal cancer per 10000 procedures of ablations, electrophysiology, CA and PTCA cases, respectively. Conclusion: Results showed that the radiation risk due to RF cardiac ablation is higher than the other complication procedures so, efforts should be made to minimize patient radiation risk from RF ablation procedures. Also we found no clear correlation between cardiologist level of experience and reduced level of patient’s dose.
背景:心导管插入术在评估疑似心力衰竭患者中起着至关重要的作用。这项工作旨在确定接受导管插入术检查的患者的平均有效剂量,并估计恶性肿瘤的相关辐射风险。材料和方法:在一个专门的实验室中,在65次冠状动脉造影(CA)、70次冠状动脉血管成形术(PTCA)27、射频透视(RF)消融和25次电生理过程中进行测量。这些程序是用西门子和通用电气的X射线设备进行的。还使用了剂量-面积乘积(DAP)计。记录每位患者的DAP值和荧光镜检查时间。结果:CA的DAP平均值和患者有效剂量分别为19.53 Gy.cm和1.71 mSv,PTCA为49.74 Gy.cm2和4.57 mSv,消融为153.34 Gy.cm或16.38 mSv,电生理为14.88 Gy.cm及1.65 mSv。据估计,每10000例消融、电生理、CA和PTCA病例中,患者的辐射风险分别为13、1.3、1.3、3.6致命癌症。结论:结果表明,射频心脏消融术的辐射风险高于其他并发症,因此应努力将射频消融术对患者的辐射风险降至最低。此外,我们还发现心脏病专家的经验水平和患者剂量水平的降低之间没有明确的相关性。
{"title":"Patient radiation dosimetry during interventional cardiac procedures","authors":"F. Omidvar, F. Bouzarjomehri, F. Falahati, M. Zare","doi":"10.18869/ACADPUB.IJRR.18.3.511","DOIUrl":"https://doi.org/10.18869/ACADPUB.IJRR.18.3.511","url":null,"abstract":"Background: Cardiac catheterization plays an essential role in the evaluation of suspected heart failure patients. This work aimed to determine the mean effective dose of patients undergoing catheterization tests and to estimate the associated radiation risk of malignancy. Material and Methods: Measurements were performed during 65 coronary angiographies (CA), 70 coronary angioplasties (PTCA) 27, radio fluoroscopy (RF) ablations and 25 electro physiologies procedures in a dedicated laboratory. The procedures were undertaken with the Siemens and General Electric X-ray equipment. A dose area product (DAP) meter was also used. The DAP values and fluoroscopy times were recorded for each patient. Results: The mean DAP values and patient effective doses were 19.53 Gy.cm and 1.71 mSv for CA, 49.74 Gy.cm2 and 4.57 mSv for PTCA, 153.34 Gy.cm and 16.38 mSv for ablations and 14.88 Gy.cm and 1.65 mSv for electrophysiology, respectively. The patient radiation risk was estimated at 13, 1.3, 1.3, 3.6 fatal cancer per 10000 procedures of ablations, electrophysiology, CA and PTCA cases, respectively. Conclusion: Results showed that the radiation risk due to RF cardiac ablation is higher than the other complication procedures so, efforts should be made to minimize patient radiation risk from RF ablation procedures. Also we found no clear correlation between cardiologist level of experience and reduced level of patient’s dose.","PeriodicalId":14498,"journal":{"name":"Iranian Journal of Radiation Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42869113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Effect of lung inhomogeneity on dose distribution during radiotherapy of patient with lung cancer 肺不均匀性对癌症放疗剂量分布的影响
Q4 Health Professions Pub Date : 2020-07-10 DOI: 10.18869/ACADPUB.IJRR.18.3.579
M. Zabihzadeh, Z. Ghahremani, S. Hoseini, H. Shahbazian, M. H. Ghahfarokhi
Background: Presence of inhomogeneities such as lung tissue with low density can perturbs the dose distribution in the path of therapeutic photon beam and causes undesired cold or hot spots. The aim of this study was to investigate the effect of lung tissue inhomogeneities on dose distribution in thorax irradiation. Materials and Methods: The Monte Carlo simulation (MC) code of EGSnrc-based BEAMnrc was used to calculate dose distribution for 6 MVSiemens Primus linear accelerator (Linac) in a homogenous phantom. Dose perturbation and inhomogeneity corrected factors (ICFs) were calculated due to implementation of lung tissue depended to the lung density and field size. Results: The maximum increased dose in lung tissue with lung density of 0.5 and 0.25gr/cm was 15.9%, 16.2%, 15.6%, 23.8 %, 24.8% and 25.0% for 6 × 6, 10 × 10 and 20 × 20 cm field sizes, respectively. The maximum ICF for these field sizes was 1.16 and 1.25 for lung density of 0.5 and 0.25gr/cm, respectively. The maximum dose reduction in lung tissue with density of 0.25 and 0.5gr/cm was 19.5% and 4.2 %, and the related ICF was estimated 0.84 and 0.95, respectively. Conclusion: Involvement of lung tissue in the path of irradiation perturbs the dose distribution which is dependent to the lung density and field size. The ICFs resulted from our MC model could be useful to accurately calculate the dose distribution in radiotherapy of lung abnormalities.
背景:不均匀性的存在,如低密度的肺组织,会干扰治疗光子束路径中的剂量分布,并导致不希望的冷点或热点。本研究的目的是研究胸部照射中肺组织不均匀性对剂量分布的影响。材料和方法:使用基于EGSnrc的BEAMnrc的蒙特卡罗模拟(MC)程序计算了6MV西门子Primus线性加速器(Linac)在均质体模中的剂量分布。由于肺组织的实施取决于肺密度和场大小,因此计算了剂量扰动和不均匀性校正因子(ICFs)。结果:在肺密度为0.5和0.25gr/cm的肺组织中,6×6、10×10和20×20cm视野的最大增加剂量分别为15.9%、16.2%、15.6%、23.8%、24.8%和25.0%。当肺密度为0.5和0.25gr/cm时,这些场大小的最大ICF分别为1.16和1.25。在密度为0.25和0.5gr/cm的肺组织中,最大剂量减少分别为19.5%和4.2%,相关ICF估计分别为0.84和0.95。结论:肺组织参与照射路径会干扰剂量分布,剂量分布与肺密度和视野大小有关。我们的MC模型产生的ICFs可用于准确计算肺部异常放射治疗中的剂量分布。
{"title":"Effect of lung inhomogeneity on dose distribution during radiotherapy of patient with lung cancer","authors":"M. Zabihzadeh, Z. Ghahremani, S. Hoseini, H. Shahbazian, M. H. Ghahfarokhi","doi":"10.18869/ACADPUB.IJRR.18.3.579","DOIUrl":"https://doi.org/10.18869/ACADPUB.IJRR.18.3.579","url":null,"abstract":"Background: Presence of inhomogeneities such as lung tissue with low density can perturbs the dose distribution in the path of therapeutic photon beam and causes undesired cold or hot spots. The aim of this study was to investigate the effect of lung tissue inhomogeneities on dose distribution in thorax irradiation. Materials and Methods: The Monte Carlo simulation (MC) code of EGSnrc-based BEAMnrc was used to calculate dose distribution for 6 MVSiemens Primus linear accelerator (Linac) in a homogenous phantom. Dose perturbation and inhomogeneity corrected factors (ICFs) were calculated due to implementation of lung tissue depended to the lung density and field size. Results: The maximum increased dose in lung tissue with lung density of 0.5 and 0.25gr/cm was 15.9%, 16.2%, 15.6%, 23.8 %, 24.8% and 25.0% for 6 × 6, 10 × 10 and 20 × 20 cm field sizes, respectively. The maximum ICF for these field sizes was 1.16 and 1.25 for lung density of 0.5 and 0.25gr/cm, respectively. The maximum dose reduction in lung tissue with density of 0.25 and 0.5gr/cm was 19.5% and 4.2 %, and the related ICF was estimated 0.84 and 0.95, respectively. Conclusion: Involvement of lung tissue in the path of irradiation perturbs the dose distribution which is dependent to the lung density and field size. The ICFs resulted from our MC model could be useful to accurately calculate the dose distribution in radiotherapy of lung abnormalities.","PeriodicalId":14498,"journal":{"name":"Iranian Journal of Radiation Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49252314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dosimetric comparison of conventional and field-in-field techniques in early-stage breast cancer radiotherapy 早期乳腺癌放疗常规与现场放射技术的剂量学比较
Q4 Health Professions Pub Date : 2020-07-10 DOI: 10.18869/ACADPUB.IJRR.18.3.487
S. Hosseini, M. Momennezhad, S. Naseri
{"title":"Dosimetric comparison of conventional and field-in-field techniques in early-stage breast cancer radiotherapy","authors":"S. Hosseini, M. Momennezhad, S. Naseri","doi":"10.18869/ACADPUB.IJRR.18.3.487","DOIUrl":"https://doi.org/10.18869/ACADPUB.IJRR.18.3.487","url":null,"abstract":"","PeriodicalId":14498,"journal":{"name":"Iranian Journal of Radiation Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43955222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcome of stereotactic body radiotherapy for localized prostate cancer: long-term results 立体定向放射治疗局限性前列腺癌的临床效果:远期效果
Q4 Health Professions Pub Date : 2020-07-10 DOI: 10.18869/ACADPUB.IJRR.18.3.381
H. Kim, Jung-Sub Lee, W. Kim
{"title":"Clinical outcome of stereotactic body radiotherapy for localized prostate cancer: long-term results","authors":"H. Kim, Jung-Sub Lee, W. Kim","doi":"10.18869/ACADPUB.IJRR.18.3.381","DOIUrl":"https://doi.org/10.18869/ACADPUB.IJRR.18.3.381","url":null,"abstract":"","PeriodicalId":14498,"journal":{"name":"Iranian Journal of Radiation Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42919643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of adrenomeduline and ramp2 on the lung of mice exposed to total body radiation 肾上腺素和ramp2对全身辐射小鼠肺部的影响
Q4 Health Professions Pub Date : 2020-07-10 DOI: 10.18869/ACADPUB.IJRR.18.3.571
M. K. Ozbilgin, G. Z. Karaman, S. Gencur, E. Gumustepe, C. Kurtman
Background: Adrenomedullin (AM) and its receptor, receptor activitymodifying protein (RAMP) 2 have pleiotropic regulatory functions in normal tissue and cancer tissue. AM is produced and secreted both numerous stromal cells and tumor cells. This study aims to investigate a possible role of AM and RAMP2 in the radiation exposure in the normal lung tissue. Materials and Methods: Four groups with 6 male adult Swiss Albino mice per group were investigated. The mice were subjected to a 500 cGy single-dose radiation exposure in the total body radiation device and lung tissues were collected. 1, 2, and 7 days after radiation exposure, with 1 reference group which was not exposed to radiation. Results: The general histology and the immunohistochemistry of the tissue samples prepared with antiAM, anti– RAMP2, and monoclonal antibodies were investigated, yielding a statistically significant increase for AM on day 3 and for RAMP2 on day 1 after radiation exposure. Conclusion: The observed increase of AM and RAMP2 concentrations in the normal tissue matrix after radiation exposure may play a role in the side effects of radiotherapy.
背景:肾上腺髓质素(AM)及其受体受体活性修饰蛋白(RAMP) 2在正常组织和肿瘤组织中具有多效性调节功能。AM在许多基质细胞和肿瘤细胞中都有产生和分泌。本研究旨在探讨AM和RAMP2在正常肺组织辐射暴露中的可能作用。材料与方法:分为4组,每组6只雄性成年瑞士白化小鼠。小鼠在全身辐射装置中接受500 cGy单剂量辐射照射,并收集肺组织。照射后1、2、7天,1个参照组未照射。结果:对抗AM、抗RAMP2和单克隆抗体制备的组织样本进行一般组织学和免疫组织化学分析,发现辐射后第3天AM和第1天RAMP2的表达均有统计学意义的增加。结论:放疗后正常组织基质中AM和RAMP2浓度的升高可能与放疗副反应有关。
{"title":"Effects of adrenomeduline and ramp2 on the lung of mice exposed to total body radiation","authors":"M. K. Ozbilgin, G. Z. Karaman, S. Gencur, E. Gumustepe, C. Kurtman","doi":"10.18869/ACADPUB.IJRR.18.3.571","DOIUrl":"https://doi.org/10.18869/ACADPUB.IJRR.18.3.571","url":null,"abstract":"Background: Adrenomedullin (AM) and its receptor, receptor activitymodifying protein (RAMP) 2 have pleiotropic regulatory functions in normal tissue and cancer tissue. AM is produced and secreted both numerous stromal cells and tumor cells. This study aims to investigate a possible role of AM and RAMP2 in the radiation exposure in the normal lung tissue. Materials and Methods: Four groups with 6 male adult Swiss Albino mice per group were investigated. The mice were subjected to a 500 cGy single-dose radiation exposure in the total body radiation device and lung tissues were collected. 1, 2, and 7 days after radiation exposure, with 1 reference group which was not exposed to radiation. Results: The general histology and the immunohistochemistry of the tissue samples prepared with antiAM, anti– RAMP2, and monoclonal antibodies were investigated, yielding a statistically significant increase for AM on day 3 and for RAMP2 on day 1 after radiation exposure. Conclusion: The observed increase of AM and RAMP2 concentrations in the normal tissue matrix after radiation exposure may play a role in the side effects of radiotherapy.","PeriodicalId":14498,"journal":{"name":"Iranian Journal of Radiation Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46325189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why can COVID-19 fatality in space be significantly higher than on Earth? 为什么太空中的新冠肺炎致死率会显著高于地球?
Q4 Health Professions Pub Date : 2020-07-01 DOI: 10.18869/ACADPUB.IJRR.18.3.421
J. Welsh, J. Bevelacqua, H. Mozdarani, S. Mortazavi, S. Mortazavi
Astronauts are exposed to a wide variety of stressors ranging from radiation and microgravity to persistent fluids shifts, circadian shifts and the psychological stress of prolonged isolation and confinement. On deep space missions, beyond the range of the Earth's magnetosphere, ionizing radiation may increase oxidative stress and DNA damage, immune system dysregulation and alter the effectiveness of the cellular defense mechanisms. By reviewing the health problems reported by astronauts participated in previous space missions, it is evident that viral infections are not rare in space. Recent reports suggest that COVID-19 can last for a long time in communities. Although NASA implements countermeasures designed to limit crew illness during space missions such as a pre-flight quarantine, it is not clear whether an outbreak can be prevented. Currently, it is not likely that astronauts could get a viral infection, but the consequences of potential lifethreatening viral diseases such as COVID-19 should be better characterized. In this paper we discuss why COVID-19 fatality in space might be significantly higher than on the Earth. The reasons for such an increased risk include 1) uselessness of social distancing due to microgravity 2) immune system dysregulation 3) possibly higher mutation rates of RNA viruses such as the novel coronavirus (SARS-CoV-2) 4) existence of strong selective pressure and 5) decreased maximum oxygen uptake. Given these considerations, the combined effects of microgravity, space radiation (and possibly other major space stressors) on the immune system of astronauts exposed to SARS-CoV-2 and possible interactions of the virus, space stressors and host should be carefully investigated.
宇航员面临着各种各样的压力,从辐射和微重力到持续的体液变化、昼夜节律变化以及长期隔离和禁闭带来的心理压力。在地球磁层范围之外的深空任务中,电离辐射可能会增加氧化应激和DNA损伤、免疫系统失调,并改变细胞防御机制的有效性。通过回顾之前参与太空任务的宇航员报告的健康问题,很明显,病毒感染在太空中并不罕见。最近的报告表明,新冠肺炎可能在社区持续很长一段时间。尽管美国国家航空航天局在执行太空任务期间实施了旨在限制机组人员患病的应对措施,如飞行前隔离,但尚不清楚是否可以预防疫情爆发。目前,宇航员不太可能感染病毒,但应该更好地描述新冠肺炎等潜在威胁生命的病毒性疾病的后果。在这篇论文中,我们讨论了为什么新冠肺炎在太空中的致死率可能显著高于地球。这种风险增加的原因包括1)微重力导致社交距离的无用性2)免疫系统失调3)新型冠状病毒(SARS-CoV-2)等RNA病毒的突变率可能更高4)存在强大的选择压力和5)最大摄氧量降低。考虑到这些因素,应仔细研究微重力、太空辐射(可能还有其他主要太空压力源)对暴露于严重急性呼吸系统综合征冠状病毒2型的宇航员免疫系统的综合影响,以及病毒、太空压力源和宿主的可能相互作用。
{"title":"Why can COVID-19 fatality in space be significantly higher than on Earth?","authors":"J. Welsh, J. Bevelacqua, H. Mozdarani, S. Mortazavi, S. Mortazavi","doi":"10.18869/ACADPUB.IJRR.18.3.421","DOIUrl":"https://doi.org/10.18869/ACADPUB.IJRR.18.3.421","url":null,"abstract":"Astronauts are exposed to a wide variety of stressors ranging from radiation and microgravity to persistent fluids shifts, circadian shifts and the psychological stress of prolonged isolation and confinement. On deep space missions, beyond the range of the Earth's magnetosphere, ionizing radiation may increase oxidative stress and DNA damage, immune system dysregulation and alter the effectiveness of the cellular defense mechanisms. By reviewing the health problems reported by astronauts participated in previous space missions, it is evident that viral infections are not rare in space. Recent reports suggest that COVID-19 can last for a long time in communities. Although NASA implements countermeasures designed to limit crew illness during space missions such as a pre-flight quarantine, it is not clear whether an outbreak can be prevented. Currently, it is not likely that astronauts could get a viral infection, but the consequences of potential lifethreatening viral diseases such as COVID-19 should be better characterized. In this paper we discuss why COVID-19 fatality in space might be significantly higher than on the Earth. The reasons for such an increased risk include 1) uselessness of social distancing due to microgravity 2) immune system dysregulation 3) possibly higher mutation rates of RNA viruses such as the novel coronavirus (SARS-CoV-2) 4) existence of strong selective pressure and 5) decreased maximum oxygen uptake. Given these considerations, the combined effects of microgravity, space radiation (and possibly other major space stressors) on the immune system of astronauts exposed to SARS-CoV-2 and possible interactions of the virus, space stressors and host should be carefully investigated.","PeriodicalId":14498,"journal":{"name":"Iranian Journal of Radiation Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47500648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
Iranian Journal of Radiation Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1